SELLAS Life Sciences Group Inc — Quarterly Cash Flow (NASDAQ:SLS) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Total assets 19.43 M34.96 M32.3 M51.55 M78.34 M Total liabilities 9.97 M7.2 M6.16 M5.92 M7.47 M Total equity 9.46 M27.76 M26.15 M45.63 M70.87 M Total liabilities & shareholders' equities 19.43 M34.96 M32.3 M51.55 M78.34 M Total debt ————— Net debt —————

뉴스

SELLAS, 2상 AML 임상시험 첫 환자 등록

SELLAS enrolls first patient in Phase 2 AML trial of SLS009

셀라스 생명과학, 워런트 행사로 4,260만 달러 조달

Sellas Life Sciences reports $42.6 million in warrant exercise proceeds

What's Going With SELLAS Life Sciences Stock On Wednesday? - SELLAS Life Sciences Gr (NASDAQ:SLS)

H.C. Wainwright, Solaris Resources 목표 주가 16달러로 상향

H.C. Wainwright raises Solaris Resources stock price target to $16 on Warintza progress

Why I’m Selling Sellas Life Sciences Ahead Of The REGAL Reveal (NASDAQ:SLS)

Solaris Resources, 52주 신고가 $8.54 기록

SELLAS, 유럽서 SLS009 임상시험 위해 IMPACT-AML과 협력

SELLAS partners with IMPACT-AML for European SLS009 trials

Lam Research, Micron Tech among market cap stock movers on Tuesday